Savvy investors eyeing the next big thing in China should consider cigarettes, nicotine gum and cancer-treatment providers.
That is the upshot of a new Brookings Institution report that raises burning questions about the family of Li Keqiang. He is expected to be named China’s next premier at a Communist Party congress that begins on Thursday. Li’s brother, Li Keming, is deputy director at China’s State Tobacco Monopoly Administration, which dominates an industry that some health officials estimate will kill 3.5 million people each year in the country by 2030.
looking beyond borders 